Literature DB >> 11283070

Definition of a divergent epitope that allows differential detection of early protein p41 from human herpesvirus 6 variants A and B.

Y Xu1, A Linde, H Dahl, G Winberg.   

Abstract

The human herpesvirus 6 (HHV-6) early protein, p41, encoded by the U27 gene has been detected in oligodendrocytes of multiple sclerosis (MS) patients by using a monoclonal antibody (MAb to p41/38). We here report the antigenic epitope of HHV-6 p41 recognized by this MAb. First, we established that the MAb to p41/38 recognizes a nuclear antigen in HHV-6A strain GS-infected cells but not in HHV-6B strain Z29-infected cells. Secondly, we compared the reactivity of the MAb to p41/38 to that of another p41-specific MAb (MAb to p41) on immunoblots with purified p41-glutathione S-transferase fusion protein from strains GS and Z29 and GS- and Z29-infected-cell lysates. The two MAbs were tested in an enzyme-linked immunosorbent assay against a panel of synthetic peptides covering the amino acid substitutions between the GS- and Z29-derived p41 proteins, as determined by DNA sequencing of our cloned isolates of the U27 gene. The MAb to p41/38 reacted specifically with a peptide comprising p41 residues 321 to 340 from strain GS. The critical residue in this peptide was serine 328, as the substitution S328N in the Z29 strain rendered the corresponding peptide nonreactive. The p41 S328 marker was present in three of three HHV-6A strains, while four of four sequenced p41 genes from HHV-6B strains had N328. Our findings are of value for the interpretation of previous findings of p41 expression in brains of MS patients and may allow a more detailed analysis of the role of HHV-6 variants in other disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283070      PMCID: PMC87953          DOI: 10.1128/JCM.39.4.1449-1455.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Improved retroviral vectors for gene transfer and expression.

Authors:  A D Miller; G J Rosman
Journal:  Biotechniques       Date:  1989-10       Impact factor: 1.993

2.  CD4 is not the membrane receptor for HHV-6.

Authors:  P Lusso; R C Gallo; S E DeRocco; P D Markham
Journal:  Lancet       Date:  1989-04-01       Impact factor: 79.321

3.  Identification of proteins specific for human herpesvirus 6-infected human T cells.

Authors:  N Balachandran; R E Amelse; W W Zhou; C K Chang
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Characteristics of human herpesvirus-6.

Authors:  C Lopez; P Pellett; J Stewart; C Goldsmith; K Sanderlin; J Black; D Warfield; P Feorino
Journal:  J Infect Dis       Date:  1988-06       Impact factor: 5.226

5.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

6.  Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A.

Authors:  C B Hall; M T Caserta; K C Schnabel; C Long; L G Epstein; R A Insel; S Dewhurst
Journal:  Clin Infect Dis       Date:  1998-01       Impact factor: 9.079

7.  Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates.

Authors:  D V Ablashi; N Balachandran; S F Josephs; C L Hung; G R Krueger; B Kramarsky; S Z Salahuddin; R C Gallo
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

8.  Identification, characterization, and sequence analysis of a cDNA encoding a phosphoprotein of human herpesvirus 6.

Authors:  C K Chang; N Balachandran
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

10.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.